EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24825 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Chaobin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Liaocheng People's Hospital, Liaocheng, China. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shandong provincial Natural Science Fundation.
Abstract (Originalsprache)
Background
As EIF3D is oncogenic in colorectal cancer (CRC) and is associated with multidrug resistance, this study aims to investigate whether and how EIF3D regulates resistance to 5‐fluorouracil (5‐Fu) in CRC.
Methods
EIF3D‐associated genes in CRC were predicted using bioinformatics tools. CRC cells and nude mice received 5‐Fu treatment. Then, the impacts of EIF3D and the interaction between EIF3D and RUVBL1 on cell viability, colony formation, apoptosis, and DNA damage were detected through MTT, colony formation, flow cytometry, and immunofluorescence assays, and those on in vivo tumorigenesis through murine xenograft assay. IC50 value of 5‐Fu for CRC cells was determined by probit regression analysis. Expressions of EIF3D, eIF4E, EIF3D‐associated genes, γH2AX, Bcl‐2, Bax, and Cleaved Caspase‐3/Caspase‐3 in CRC tissues, cells, and/or xenograft tumors were analyzed by qRT‐PCR and/or Western blot.
Results
EIF3D and RUVBL1 were highly expressed and positively correlated with CRC tissues/cells. In CRC cells, except for eIF4E, both EIF3D and RUVBL1 levels were upregulated by 5‐Fu treatment; in addition to that, RUVBL1 level was downregulated by EIF3D silencing rather than eIF4E. Meanwhile, EIF3D silencing diminished IC50 value of 5‐Fu and potentiated 5‐Fu‐induced viability decrease, colony formation inhibition, apoptosis promotion, Bcl‐2 downregulation, and γH2AX, Bax, and Cleaved Caspase‐3/Caspase‐3 upregulation but reversed 5‐Fu‐triggered RUVBL1 upregulation. RUVBL1 overexpression offsets EIF3D silencing‐induced viability decrease and apoptosis promotion of 5‐Fu‐treated CRC cells, and tumorigenesis suppression and apoptosis promotion in 5‐Fu‐treated mice.
Conclusion
EIF3D promotes resistance to 5‐Fu in CRC through upregulating RUVBL1 level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Department, Liaocheng People's Hospital, Liaocheng, China.
- Gastrointestinal Surgery Department, Liaocheng People's Hospital, Liaocheng, China.
ORCID-Profile: Kemei Lu
Förderung
- Shandong provincial Natural Science Fundation
Zitieren
APA
Li, C., Lu, K., Yang, C., Du, W., & Liang, Z. (2023). EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24825
Vancouver
Li C, Lu K, Yang C, Du W, Liang Z. EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24825
BibTeX
@article{Li2023,
author = {Li, Chaobin and Lu, Kemei and Yang, Chenggang and Du, Wenfeng and Liang, Zhengkai},
title = {EIF3D promotes resistance to 5‐fluorouracil in colorectal cancer through upregulating RUVBL1},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24825}
}
EUVIMED